LRRTM1
Basic information
Region (hg38): 2:80288351-80304752
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LRRTM1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 28 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 2 | 2 |
Variants in LRRTM1
This is a list of pathogenic ClinVar variants found in the LRRTM1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-80302418-G-A | not specified | Uncertain significance (Oct 27, 2022) | ||
2-80302444-T-C | not specified | Uncertain significance (Apr 18, 2023) | ||
2-80302463-A-G | not specified | Uncertain significance (Sep 14, 2022) | ||
2-80302478-C-G | not specified | Uncertain significance (Dec 20, 2023) | ||
2-80302520-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
2-80302530-C-T | Likely benign (May 01, 2023) | |||
2-80302548-C-G | not specified | Uncertain significance (Sep 20, 2023) | ||
2-80302571-C-T | not specified | Uncertain significance (Feb 27, 2023) | ||
2-80302595-C-T | not specified | Uncertain significance (May 04, 2023) | ||
2-80302610-C-G | not specified | Uncertain significance (Apr 08, 2022) | ||
2-80302613-C-A | Benign (May 01, 2024) | |||
2-80302621-C-G | not specified | Uncertain significance (May 05, 2023) | ||
2-80302637-C-T | not specified | Uncertain significance (Apr 20, 2024) | ||
2-80302664-G-T | not specified | Uncertain significance (Aug 30, 2022) | ||
2-80302716-C-G | not specified | Uncertain significance (Jun 23, 2021) | ||
2-80302728-C-G | not specified | Uncertain significance (Mar 24, 2023) | ||
2-80302759-A-T | not specified | Uncertain significance (Jan 17, 2024) | ||
2-80302772-C-T | not specified | Uncertain significance (Jun 06, 2023) | ||
2-80302798-T-C | not specified | Uncertain significance (Dec 08, 2023) | ||
2-80302808-C-T | Benign (Apr 03, 2018) | |||
2-80302817-G-A | not specified | Uncertain significance (Aug 13, 2021) | ||
2-80302843-G-A | not specified | Uncertain significance (Apr 14, 2022) | ||
2-80302877-G-C | not specified | Uncertain significance (Dec 22, 2023) | ||
2-80302955-A-G | not specified | Uncertain significance (Dec 14, 2023) | ||
2-80303026-C-T | not specified | Uncertain significance (Feb 22, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LRRTM1 | protein_coding | protein_coding | ENST00000295057 | 1 | 16392 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.595 | 0.405 | 125744 | 0 | 4 | 125748 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.42 | 230 | 299 | 0.769 | 0.0000141 | 3390 |
Missense in Polyphen | 83 | 135.02 | 0.61473 | 1658 | ||
Synonymous | -0.466 | 149 | 142 | 1.05 | 0.00000711 | 1090 |
Loss of Function | 2.98 | 3 | 15.8 | 0.190 | 6.91e-7 | 150 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000579 | 0.0000579 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000880 | 0.00000879 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Exhibits strong synaptogenic activity, restricted to excitatory presynaptic differentiation, acting at both pre- and postsynaptic level. {ECO:0000250}.;
- Pathway
- Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
(Consensus)
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- 0.138
- rvis_EVS
- 0.11
- rvis_percentile_EVS
- 62
Haploinsufficiency Scores
- pHI
- 0.597
- hipred
- Y
- hipred_score
- 0.837
- ghis
- 0.530
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.238
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lrrtm1
- Phenotype
- homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- negative regulation of receptor internalization;locomotory behavior;biological_process;protein localization to synapse;exploration behavior;synapse organization;positive regulation of synapse assembly;long-term synaptic potentiation;regulation of postsynaptic density assembly;regulation of presynapse assembly
- Cellular component
- extracellular space;endoplasmic reticulum;cell surface;cell junction;axon;growth cone;extracellular matrix;excitatory synapse;glutamatergic synapse;GABA-ergic synapse;integral component of postsynaptic specialization membrane
- Molecular function
- molecular_function